TOI Insider Trading

Insider Ownership Percentage: 9.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $312,277.74

Oncology Institute Insider Trading History Chart

This chart shows the insider buying and selling history at Oncology Institute by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncology Institute Share Price & Price History

Current Price: $0.32
Price Change: Price Decrease of -0.01 (-3.07%)
As of 10/11/2024 01:00 AM ET

This chart shows the closing price history over time for TOI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oncology Institute Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2024Havencrest Healthcare PartnersMajor ShareholderSell8,637$2.12$18,310.44View SEC Filing Icon  
1/26/2024Havencrest Healthcare PartnersMajor ShareholderSell6,979$2.14$14,935.068,637View SEC Filing Icon  
1/24/2024Havencrest Healthcare PartnersMajor ShareholderSell24,915$2.30$57,304.5027,498View SEC Filing Icon  
1/22/2024Havencrest Healthcare PartnersMajor ShareholderSell10,263$2.12$21,757.5657,751View SEC Filing Icon  
1/19/2024Havencrest Healthcare PartnersMajor ShareholderSell11,986$2.13$25,530.1868,014View SEC Filing Icon  
11/17/2023Brad HivelyDirectorSell25,000$2.24$56,000.00697,065View SEC Filing Icon  
11/13/2023Brad HivelyDirectorSell47,000$2.52$118,440.00724,182View SEC Filing Icon  
3/17/2023Richard A BaraschDirectorBuy50,000$0.55$27,500.00257,193View SEC Filing Icon  
12/16/2022Matthew P MillerCOOBuy73,684$0.95$69,999.80175,325View SEC Filing Icon  
11/14/2022Mohit KaushalDirectorSell15,994$2.13$34,067.2225,534View SEC Filing Icon  
11/11/2022Havencrest Healthcare PartnersMajor ShareholderSell365,321$2.33$851,197.9313,362,873View SEC Filing Icon  
11/9/2022Havencrest Healthcare PartnersMajor ShareholderSell80,000$3.09$247,200.0013,789,475View SEC Filing Icon  
11/7/2022Havencrest Healthcare PartnersMajor ShareholderSell19,167$3.28$62,867.7613,896,475View SEC Filing Icon  
11/4/2022Havencrest Healthcare PartnersMajor ShareholderSell50,200$3.39$170,178.0013,915,642View SEC Filing Icon  
11/2/2022Havencrest Healthcare PartnersMajor ShareholderSell58,500$3.94$230,490.0014,011,342View SEC Filing Icon  
10/31/2022Havencrest Healthcare PartnersMajor ShareholderSell41,855$4.69$196,299.9514,120,114View SEC Filing Icon  
10/28/2022Havencrest Healthcare PartnersMajor ShareholderSell52,091$4.84$252,120.4414,161,969View SEC Filing Icon  
10/26/2022Havencrest Healthcare PartnersMajor ShareholderSell52,500$5.16$270,900.0014,249,060View SEC Filing Icon  
10/24/2022Havencrest Healthcare PartnersMajor ShareholderSell29,400$4.98$146,412.0014,331,960View SEC Filing Icon  
10/24/2022Mohit KaushalDirectorSell4,798$4.96$23,798.0841,528View SEC Filing Icon  
10/20/2022Havencrest Healthcare PartnersMajor ShareholderSell12,000$4.83$57,960.0014,381,360View SEC Filing Icon  
10/17/2022Havencrest Healthcare PartnersMajor ShareholderSell8,249$4.60$37,945.4014,423,060View SEC Filing Icon  
10/14/2022Havencrest Healthcare PartnersMajor ShareholderSell9,800$4.54$44,492.0014,431,309View SEC Filing Icon  
10/12/2022Havencrest Healthcare PartnersMajor ShareholderSell14,343$4.70$67,412.1014,466,309View SEC Filing Icon  
10/10/2022Havencrest Healthcare PartnersMajor ShareholderSell21,500$4.33$93,095.0014,505,652View SEC Filing Icon  
10/7/2022Havencrest Healthcare PartnersMajor ShareholderSell14,652$4.63$67,838.7614,527,152View SEC Filing Icon  
10/5/2022Havencrest Healthcare PartnersMajor ShareholderSell14,060$4.78$67,206.8014,575,313View SEC Filing Icon  
10/3/2022Havencrest Healthcare PartnersMajor ShareholderSell16,765$4.72$79,130.8014,612,820View SEC Filing Icon  
9/30/2022Havencrest Healthcare PartnersMajor ShareholderSell11,000$4.68$51,480.0014,629,585View SEC Filing Icon  
9/28/2022Havencrest Healthcare PartnersMajor ShareholderSell12,642$4.72$59,670.2414,661,585View SEC Filing Icon  
9/26/2022Havencrest Healthcare PartnersMajor ShareholderSell7,153$4.57$32,689.2114,688,301View SEC Filing Icon  
9/22/2022Havencrest Healthcare PartnersMajor ShareholderSell13,086$4.25$55,615.5014,700,829View SEC Filing Icon  
9/19/2022Havencrest Healthcare PartnersMajor ShareholderSell19,629$4.33$84,993.5714,713,915View SEC Filing Icon  
9/16/2022Havencrest Healthcare PartnersMajor ShareholderSell200,000$4.50$900,000.0014,733,544View SEC Filing Icon  
9/14/2022Havencrest Healthcare PartnersMajor ShareholderSell37,785$4.99$188,547.1515,002,044View SEC Filing Icon  
9/12/2022Havencrest Healthcare PartnersMajor ShareholderSell38,000$5.52$209,760.0015,092,329View SEC Filing Icon  
9/9/2022Havencrest Healthcare PartnersMajor ShareholderSell18,900$5.80$109,620.0015,130,329View SEC Filing Icon  
9/7/2022Havencrest Healthcare PartnersMajor ShareholderSell45,000$6.04$271,800.0015,172,729View SEC Filing Icon  
8/31/2022Havencrest Healthcare PartnersMajor ShareholderSell25,000$6.36$159,000.0015,375,212View SEC Filing Icon  
8/29/2022Havencrest Healthcare PartnersMajor ShareholderSell15,000$6.14$92,100.0015,438,712View SEC Filing Icon  
8/26/2022Havencrest Healthcare PartnersMajor ShareholderSell40,000$6.03$241,200.0015,453,712View SEC Filing Icon  
8/24/2022Havencrest Healthcare PartnersMajor ShareholderSell21,084$6.37$134,305.0815,497,237View SEC Filing Icon  
8/22/2022Havencrest Healthcare PartnersMajor ShareholderSell35,500$6.53$231,815.0015,566,421View SEC Filing Icon  
8/19/2022Havencrest Healthcare PartnersMajor ShareholderSell10,873$6.81$74,045.1315,601,921View SEC Filing Icon  
8/15/2022Havencrest Healthcare PartnersMajor ShareholderSell16,663$6.23$103,810.4915,621,231View SEC Filing Icon  
8/12/2022Havencrest Healthcare PartnersMajor ShareholderSell24,900$6.69$166,581.0015,637,894View SEC Filing Icon  
5/11/2022Richy AgajanianMajor ShareholderSell1,600,000$6.00$9,600,000.00253,436View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncology Institute (NASDAQ:TOI)

36.86% of Oncology Institute stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TOI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Oncology Institute Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2024Renaissance Technologies LLC339,400$0.16M0.0%+142.3%0.456%Search for SEC Filing on Google Icon
8/7/2024Tiff Advisory Services LLC1,418,685$0.65M0.2%+235.1%1.906%Search for SEC Filing on Google Icon
5/16/2024FourWorld Capital Management LLC250,359$0.40M0.3%N/A0.337%Search for SEC Filing on Google Icon
5/16/2024Kent Lake Capital LLC1,186,713$1.88M0.8%+9.4%1.597%Search for SEC Filing on Google Icon
5/14/2024Element Pointe Advisors LLC199,026$0.31M0.1%-50.0%0.268%Search for SEC Filing on Google Icon
5/10/2024Nwam LLC27,679$44K0.0%N/A0.037%Search for SEC Filing on Google Icon
4/18/2024Quattro Financial Advisors LLC55,960$88K0.0%N/A0.075%Search for SEC Filing on Google Icon
2/14/2024Kent Lake Capital LLC1,085,171$2.21M0.9%+492.3%1.471%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 12,046$25K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/8/2024Cincinnati Insurance Co.699,500$1.43M0.0%N/A0.948%Search for SEC Filing on Google Icon
2/7/2024Josh Arnold Investment Consultant LLC1,856,329$3.79M3.7%-1.1%2.517%Search for SEC Filing on Google Icon
2/6/2024Fielder Capital Group LLC70,192$0.14M0.1%N/A0.095%Search for SEC Filing on Google Icon
1/23/2024WealthShield Partners LLC24,126$49K0.0%N/A0.033%Search for SEC Filing on Google Icon
1/1/2024Vanguard Group Inc.1,758,034$2.46M0.0%-0.3%2.384%Search for SEC Filing on Google Icon
11/22/2023Josh Arnold Investment Consultant LLC1,877,472$2.65M2.8%+77.4%2.546%Search for SEC Filing on Google Icon
11/15/2023Kent Lake Capital LLC183,215$0.26M0.1%N/A0.251%Search for SEC Filing on Google Icon
11/14/2023Saba Capital Management L.P.94,264$0.13M0.0%-44.7%0.129%Search for SEC Filing on Google Icon
11/8/2023Vanguard Personalized Indexing Management LLC21,269$30K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/8/2023Tiff Advisory Services LLC423,405$0.59M0.5%N/A0.580%Search for SEC Filing on Google Icon
9/7/2023Triatomic Management LP904,689$0.50M0.5%+11.7%1.240%Search for SEC Filing on Google Icon
8/14/2023Prosight Management LP455,302$0.25M0.1%+61.5%0.604%Search for SEC Filing on Google Icon
5/3/2023Triatomic Management LP810,145$0.55M0.4%+56.6%1.087%Search for SEC Filing on Google Icon
2/16/2023Josh Arnold Investment Consultant LLC104,400$0.17M0.3%N/A0.140%Search for SEC Filing on Google Icon
2/14/2023Triatomic Management LP517,479$0.85M0.7%+41.5%0.695%Search for SEC Filing on Google Icon
11/16/2022Saba Capital Management L.P.348,059$1.61M0.0%-5.2%0.475%Search for SEC Filing on Google Icon
11/15/2022Parian Global Management LP240,724$1.12M3.6%+31.0%0.329%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund10,974$51K0.0%-30.5%0.015%Search for SEC Filing on Google Icon
10/26/2022Allspring Global Investments Holdings LLC10,919$50K0.0%N/A0.015%Search for SEC Filing on Google Icon
8/16/2022Parian Global Management LP183,828$0.93M4.3%-58.6%0.251%Search for SEC Filing on Google Icon
8/16/2022Deerfield Management Company L.P. Series C3,383,099$17.12M0.4%+2.6%4.617%Search for SEC Filing on Google Icon
5/17/2022Empery Asset Management LP70,733$0.50M2.4%-64.6%0.097%Search for SEC Filing on Google Icon
5/12/2022Triatomic Management LP428,100$3.05M2.5%+7.0%0.584%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd37,850$0.27M0.0%+102.5%0.052%Search for SEC Filing on Google Icon
2/15/2022Saba Capital Management L.P.400,000$3.73M0.1%N/A1.391%Search for SEC Filing on Google Icon
2/14/2022Parian Global Management LP466,676$4.55M3.7%N/A1.623%Search for SEC Filing on Google Icon
2/14/2022Redmile Group LLC2,500,000$24.38M0.6%N/A8.696%Search for SEC Filing on Google Icon
2/14/2022Deerfield Management Company L.P. Series C3,296,107$32.14M0.7%N/A11.465%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd18,688$0.18M0.0%N/A0.065%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Oncology Institute logo
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Read More on Oncology Institute

Today's Range

Now: $0.32
Low: $0.31
High: $0.33

50 Day Range

MA: $0.35
Low: $0.29
High: $0.55

52 Week Range

Now: $0.32
Low: $0.27
High: $2.66

Volume

26,411 shs

Average Volume

142,810 shs

Market Capitalization

$23.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of Oncology Institute?

Oncology Institute's top insider shareholders include:
  1. Havencrest Healthcare Partners (Major Shareholder)
  2. Brad Hively (Director)
  3. Richard A Barasch (Director)
  4. Matthew P Miller (COO)
  5. Mohit Kaushal (Director)
Learn More about top insider investors at Oncology Institute.